Fundraising Fox

Laetitia Schwab

Investor

Principal at SR One Capital Management

London

About

Laetitia Schwab is a Principal at SR One in the London office, joining in 2022. She previously worked in clinical development at Orchard Therapeutics, contributing to the delivery of the gene therapy Libmeldy for Marketing Authorisation, and has experience across early and late-phase clinical programs with expertise in gene therapy, neuroscience, and rare diseases. She holds a B.Sc in Medical Sciences from the University of Edinburgh, an MPhil in Translational Medicine and a Ph.D in Clinical Neuroscience from the University of Cambridge, and an MBA from INSEAD.

Invests in

Biotech

Experience

  1. SR One Capital ManagementPrincipalcurrent2026 β€” presentLondon, England, United Kingdom
  2. SR One Capital ManagementSenior Associate2024 β€” 2026London Area, United Kingdom
  3. SR One Capital ManagementAssociate2022 β€” 2026London Area, United Kingdom
  4. Draig TherapeuticsBoard Membercurrent2025 β€” present
  5. Addition TherapeuticsBoard Membercurrent2025 β€” present
  6. Avenzo TherapeuticsBoard Observercurrent2022 β€” present
  7. Sofinnova PartnersVenture Capital MBA Intern2021
  8. Orchard TherapeuticsSenior Clinical Development Scientist2019 β€” 2020London, United Kingdom
  9. Orchard TherapeuticsClinical Development Scientist2017 β€” 2018London, United Kingdom
  10. GSKClinical Development Intern, Rare disease unit2016London, Royaume-Uni
  11. GlaxoSmithKlineClinical Development Intern, Rare Disease Unit2012GSK House, London
  12. Sanofi Pasteur MSDClinical Development Trainee2011RΓ©gion de Lyon, France

Education

  1. INSEADMaster of Business Administration - MBA, Business Administration and Management2021
  2. University of CambridgeDoctor of Philosophy (PhD), Clinical Neuroscience2013 β€” 2016
  3. University of CambridgeMaster of Philosophy (MPhil), Clinical Science: Translational Medicine and Therapeutics2012 β€” 2013
  4. The University of EdinburghB.Sc. (Hons), Medical Sciences2009 β€” 2012
  5. Lycee Francais Charles De Gaulle, LondonBaccalaureat, Section Scientifique1999 β€” 2009

Skills & more

Pharmaceutical Industry14Microsoft Excel9Research11Neuroscience10Microsoft Office3Clinical Development5Clinical Research5Clinical Trials7Healthcare ConsultingConsulting2Life Sciences1

Languages English Β· French Β· Spanish

  • Future VC Summer 2021 β€” Future VC

From Laetitia's professional profile.

Same school

Shared employers

Deals Β· 1

Addition Therapeutics, Inc.Board seat

via SR One Capital Management Β· filed Dec 2025 Β· $28M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at SR One Capital Management